835-3 Beta-blocker dose does not influence the beneficial effects of carvedilol compared to metroprolol in the patients with heart failure: Results from the carvedilol or Metoprolol European Trial (COMET)

✍ Scribed by Marco Metra; Philip A Poole-Wilson; John G Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Willem J Remme; Armin Scherhag; Andrew Charlesworth; Christian Torp-Pedersen

• Book ID: 119548685
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 86 KB
• Volume: 43
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/s0735-1097(04)90876-5